Memorial Sloan Kettering Cancer Center’s Post

In the latest episode of my podcast, “The Immuno-Oncology Curve,” I'm joined by my Agenus colleagues Dr. Joseph Grossman and Dr. Benny Johnson. We talk about why we left the practice of medicine for Agenus. And, we reflect on this year’s #ASCO GI Cancers Symposium, covering the rise of early-onset cancers, the promising use of circulating tumor DNA (ctDNA) as a biomarker, the ongoing challenge of diversity in cancer clinical trials, and the overall potential of I-O to reduce dependence on chemotherapy and surgery. Listen and subscribe at: https://bit.ly/4bNIAzJ

High-dose vitamin D significantly reduced bone loss in patients with prostate cancer - Luke Peppone https://lnkd.in/gUTeamUV #oncodaily #oncology #cancer #research #prostatecancer #ClinicalTrials

Are you newly diagnosed with lung cancer and looking to learn more about surgery, radiation, chemotherapy, targeted therapies, or clinical trials? Or maybe you have been living with lung cancer for a while but need a refresher course? Check out the Lung Cancer Masterclass, a series of expert videos on a variety of topics to educate and empower people living with lung cancer and those who support them. Watch the entire series now by visiting https://bit.ly/47CAwP1 #lcsm #lungcancer #livingwithlungcancer

Multidisciplinary Treatment Approach for Rectal Cancer – Discussion with Drs. Deb Schrag & Krishan Jethwa The discussion revolves around the findings of the Prospect study, which explored the possibility of avoiding radiation in select rectal cancer patients to minimize long-term side effects. The study showed that outcomes were comparable between traditional treatment methods and the selective approach, with a quality-of-life advantage for the latter. The hosts and guests also touch upon the evolving paradigm of radiation therapy, the importance of MSI high status testing, and the considerations for omitting surgery in certain cases. They emphasize the need for a multidisciplinary approach and tailoring treatment based on individual patient characteristics. Overall, the episode highlights the significance of personalized treatment strategies in managing locally advanced rectal cancer and the importance of staying abreast of the latest research and advancements in the field. See Live Session: https://lnkd.in/dzEBEsyc Learn more: https://lnkd.in/d-5AhY83 #cancertreatment #oncologypodcast #oncologistsnearme

August 1 is #WorldLungCancerDay. The American Cancer Society predicts that there will be more than 100,000 deaths from #LungCancer this year. When lung cancer is found at an earlier stage before it spreads, it’s more likely to be treated successfully. That’s why it’s so important that more individuals get screened – even if they may not be experiencing symptoms. At On Target, we’re committed to helping patients and doctors fight this disease. Our targeted intraoperative molecular imaging agent helps surgeons visualize early-stage lung cancer, remove more cancer during surgery, and contributes to a world with better #LungHealth. #WLCD24   To learn more about our intraoperative molecular imaging agent and risk related information, please visit https://bit.ly/3yr0tVN

The number one way to prevent the development of colorectal cancer is to get screened early. Dr. Babak (Bobby) Rad, program director of colorectal cancer surgery at Hoag Family Cancer Institute, discusses how screening guidelines have lowered from the age of 50 to 45 due to an uptick in younger patients being diagnosed with colorectal cancer. To learn more, visit hoag.org/colorectalcancer. To schedule your colonoscopy, visit the link below. #EmpoweredbyHoag #ColorectalCancerAwarenessMonth https://lnkd.in/ghJUgXgE

Laparoscopic cholecystectomy frequently reveals gallbladder cancers (GBCs), often previously undiagnosed. Given the poor prognosis of GBC, understanding factors influencing outcomes is vital. A systematic review by Dr. Kavin Sugumar explores the prognostic significance of biliary spillage (BS)—the accidental leakage of bile during surgery—finding that BS might worsen survival rates by spreading cancer cells. These insights could reshape surgical practices and improve postoperative management for GBC patients. #TulaneResearch #Cancer #Oncology Read the paper in the comments! Image: Results from individual studies and aggregated data suggest bile spillage is associated with decreased overall survival.

Metastatic cancer is responsible for the majority of cancer-related deaths since surgery and subsequent radio- or chemotherapy often fail to remove all cancer cells. In addition, metastases frequently develop immunosuppressive resistance mechanisms protecting them from immunotherapy that work well in primary tumors. Researchers at Technische Universität München developed cells to be used in NK-or T-cell based therapies that overcome the immunosuppressive tumor microenvironment and thus retain their full cytotoxic activity. To read more click here: https://lnkd.in/ddSNnbT9

Recap ASCO 23 plenary discussion, importance of MultiD approach, as you get ready for ASCO 24 - Rahul Gosain, MD, MBA Wilmot Cancer Institute The Johns Hopkins University - Carey Business School American Society of Clinical Oncology (ASCO) #ASCO23 #ASCO24 #Cancer #OncoDaily #Oncology #RectalCancer

Mr Sheng Qiu is a Consultant Colorectal and General Surgeon with a special interest in advanced and complex colorectal cancer. Mr Qiu has experience in pelvic exenteration surgery for locally advanced and recurrent rectal cancers. He also works with liver surgeons performing simultaneous bowel and liver resections, treating patients with metastatic colorectal cancer. Mr Qiu's research interests include novel biomarkers in cancer, personalisation of cancer treatment, and the consequences of colorectal cancer treatment. Read his full profile: https://bit.ly/3U3Lo58 #LikeNoOther #BowelCancerAwarenessMonth